Literature DB >> 28384861

Molecular Characterization of Multidrug Resistant Strains of Acinetobacter baumannii Isolated from Intensive Care Units in West of Iran.

Parviz Mohajeri1, Abbas Farahani2, Rasa Sheini Mehrabzadeh3.   

Abstract

INTRODUCTION: According to the results of various studies using phenotypic methods, the prevalence of Multidrug Resistant (MDR) Acinetobacter baumannii (A. baumannii) isolates has been increasing worldwide. Pulsed-Field Gel Electrophoresis (PFGE) technique is known as the gold standard method to determine clonal characterization of bacterial species, especially A. baumannii. AIM: To determine the clonal relatedness and investigate the prevalence of integron classes 1 and 2 and genes encoding OXA-23 and 24 in A.baumanii isolates.
MATERIALS AND METHODS: A cross-sectional study was conducted from November 2011 to January 2013. A total of 140 A.baumannii isolates collected from three hospitals of Kermanshah were considered out of which 75 ICU isolates were included in this study. Antibiotics susceptibility test was done by disk diffusion method. Polymerase Chain Reaction (PCR) was performed in order to detect class 1 and 2 integrons and blaOXA-23-like, blaOXA-24-like genes. Isolates identified as MDR from a total of 75 Intensive Care Units (ICU) strains were subjected to genotyping for clonal relatedness.
RESULTS: A total of 37 isolates among 75 ICU isolates were identified as MDR. The maximum drug resistance was observed against ceftriaxone, mezlocycline, cefotaxime, piperacilin, ciprofloxacin and imipenem. Frequency of Class 1 and Class 2 Integrons, blaOXA-23-like and blaOXA-24-like genes were 33(44%), 27(36%), 60(80%) and 14(18.6%) respectively. Four clusters with high level of similarity were obtained showing homogeneity among MDR isolates.
CONCLUSION: Significant correlation between presence of integrons and resistance to different classes of antibiotic was observed in this study. Monitoring of drug resistance using gene integrase PCR and blaOXA gene by cluster analysis is very important to plan specific infection control measures due to MDR A. baumannii.

Entities:  

Keywords:  Ceftriaxone; Genotyping; Integron; OXA gene

Year:  2017        PMID: 28384861      PMCID: PMC5376806          DOI: 10.7860/JCDR/2017/21156.9397

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

1.  Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii.

Authors:  Sergio G Bartual; Harald Seifert; Corinna Hippler; M Angeles Domínguez Luzon; Hilmar Wisplinghoff; Francisco Rodríguez-Valera
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

3.  Prevalence of class 1 integron among multidrug-resistant Acinetobacter baumannii in Tabriz, northwest of Iran.

Authors:  Amir Peymani; Safar Farajnia; Mohammad Reza Nahaei; Nasrollah Sohrabi; Laleh Abbasi; Khalil Ansarin; Fatemeh Azhari
Journal:  Pol J Microbiol       Date:  2012

4.  Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.

Authors:  P Martinez-Freijo; A C Fluit; F J Schmitz; V S Grek; J Verhoef; M E Jones
Journal:  J Antimicrob Chemother       Date:  1998-12       Impact factor: 5.790

5.  Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.

Authors:  Rodrigo E Mendes; Jan M Bell; John D Turnidge; Mariana Castanheira; Ronald N Jones
Journal:  J Antimicrob Chemother       Date:  2008-10-27       Impact factor: 5.790

6.  Molecular Identification of Clinical Isolates of Mycobacterium fortuitum by Random Amplified Polymorphic DNA (RAPD) Polymerase Chain Reaction and ERIC PCR.

Authors:  Azar Dokht Khosravi; Rasa Sheini Mehrabzadeh; Abbas Farahani; Hooshang Jamali
Journal:  J Clin Diagn Res       Date:  2015-12-01

7.  Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA.

Authors:  Vijaya B Srinivasan; Govindan Rajamohan; Preeti Pancholi; Kurt Stevenson; Daniel Tadesse; Prapas Patchanee; Mario Marcon; Wondwossen A Gebreyes
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-06-17       Impact factor: 3.944

8.  Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran.

Authors:  Parviz Mohajeri; Abbas Farahani; Mohammad Mehdi Feizabadi; Hosnieh Ketabi; Ramin Abiri; Farid Najafi
Journal:  Iran J Microbiol       Date:  2013-09

9.  Class 1 integrons and antibiotic resistance of clinical Acinetobacter calcoaceticus-baumannii complex in Poznań, Poland.

Authors:  Ryszard Koczura; Beata Przyszlakowska; Joanna Mokracka; Adam Kaznowski
Journal:  Curr Microbiol       Date:  2014-04-17       Impact factor: 2.188

10.  Evaluate the frequency distribution of nonadhesive virulence factors in carbapenemase-producing Acinetobacter baumannii isolated from clinical samples in Kermanshah.

Authors:  Parviz Mohajeri; Saba Sharbati; Abbas Farahani; Zhaleh Rezaei
Journal:  J Nat Sci Biol Med       Date:  2016 Jan-Jun
View more
  2 in total

1.  Emergence of High Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Acinetobacter Species and Pseudomonas aeruginosa Among Hospitalized Patients at Dessie Comprehensive Specialized Hospital, North-East Ethiopia.

Authors:  Mihret Tilahun; Alemu Gedefie; Habitye Bisetegn; Habtu Debash
Journal:  Infect Drug Resist       Date:  2022-03-08       Impact factor: 4.003

Review 2.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.